Biomerica Inc.

AI Score

XX

Unlock

0.58
-0.04 (-6.30%)
At close: Mar 28, 2025, 3:59 PM
0.61
4.21%
After-hours: Mar 28, 2025, 06:30 PM EDT
-6.30%
Bid 0.58
Market Cap 10.71M
Revenue (ttm) 5.97M
Net Income (ttm) -6M
EPS (ttm) -0.33
PE Ratio (ttm) -1.77
Forward PE 1.75
Analyst n/a
Ask 0.65
Volume 271,915
Avg. Volume (20D) 7,670,851
Open 0.62
Previous Close 0.62
Day's Range 0.58 - 0.64
52-Week Range 0.24 - 1.27
Beta -1.17

About BMRA

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies...

Sector Healthcare
IPO Date Sep 7, 1984
Employees 64
Stock Exchange NASDAQ
Ticker Symbol BMRA
Full Company Profile
1 month ago
+9.39%
Biomerica shares are trading higher after the comp... Unlock content with Pro Subscription
2 months ago
+101.71%
Biomerica shares are trading higher after the company announced its Fortel Prostate Specific Antigen Screening Test received approval from the United Arab Emirates Ministry of Health and Prevention.